IBDEI1FF ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25300,1,5,0)
 ;;=5^SCREENING FOR DEPRESSION
 ;;^UTILITY(U,$J,358.3,25300,2)
 ;;=^295677
 ;;^UTILITY(U,$J,358.3,25301,0)
 ;;=V79.1^^147^1586^4
 ;;^UTILITY(U,$J,358.3,25301,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25301,1,4,0)
 ;;=4^V79.1
 ;;^UTILITY(U,$J,358.3,25301,1,5,0)
 ;;=5^SCREENING FOR ALCOHOLISM
 ;;^UTILITY(U,$J,358.3,25301,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,25302,0)
 ;;=V79.2^^147^1586^3
 ;;^UTILITY(U,$J,358.3,25302,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25302,1,4,0)
 ;;=4^V79.2
 ;;^UTILITY(U,$J,358.3,25302,1,5,0)
 ;;=5^SCREEN-MENTAL RETARDAT
 ;;^UTILITY(U,$J,358.3,25302,2)
 ;;=^340656
 ;;^UTILITY(U,$J,358.3,25303,0)
 ;;=V79.3^^147^1586^1
 ;;^UTILITY(U,$J,358.3,25303,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25303,1,4,0)
 ;;=4^V79.3
 ;;^UTILITY(U,$J,358.3,25303,1,5,0)
 ;;=5^SCREEN-DEVELOPMENT PROB
 ;;^UTILITY(U,$J,358.3,25303,2)
 ;;=^295680
 ;;^UTILITY(U,$J,358.3,25304,0)
 ;;=V79.8^^147^1586^2
 ;;^UTILITY(U,$J,358.3,25304,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25304,1,4,0)
 ;;=4^V79.8
 ;;^UTILITY(U,$J,358.3,25304,1,5,0)
 ;;=5^SCREEN-MENTAL DIS NEC
 ;;^UTILITY(U,$J,358.3,25304,2)
 ;;=^295681
 ;;^UTILITY(U,$J,358.3,25305,0)
 ;;=V10.00^^147^1587^9
 ;;^UTILITY(U,$J,358.3,25305,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25305,1,4,0)
 ;;=4^V10.00
 ;;^UTILITY(U,$J,358.3,25305,1,5,0)
 ;;=5^HX OF GI MALIGNANCY NOS
 ;;^UTILITY(U,$J,358.3,25305,2)
 ;;=^295202
 ;;^UTILITY(U,$J,358.3,25306,0)
 ;;=V10.01^^147^1587^21
 ;;^UTILITY(U,$J,358.3,25306,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25306,1,4,0)
 ;;=4^V10.01
 ;;^UTILITY(U,$J,358.3,25306,1,5,0)
 ;;=5^HX OF TONGUE MALIGNANCY
 ;;^UTILITY(U,$J,358.3,25306,2)
 ;;=^295203
 ;;^UTILITY(U,$J,358.3,25307,0)
 ;;=V10.02^^147^1587^38
 ;;^UTILITY(U,$J,358.3,25307,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25307,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,25307,1,5,0)
 ;;=5^HX-ORAL/PHARYNX MALG NEC
 ;;^UTILITY(U,$J,358.3,25307,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,25308,0)
 ;;=V10.03^^147^1587^25
 ;;^UTILITY(U,$J,358.3,25308,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25308,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,25308,1,5,0)
 ;;=5^HX-ESOPHAGEAL MALIGNANCY
 ;;^UTILITY(U,$J,358.3,25308,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,25309,0)
 ;;=V10.04^^147^1587^7
 ;;^UTILITY(U,$J,358.3,25309,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25309,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,25309,1,5,0)
 ;;=5^HX OF GASTRIC MALIGNANCY
 ;;^UTILITY(U,$J,358.3,25309,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,25310,0)
 ;;=V10.05^^147^1587^5
 ;;^UTILITY(U,$J,358.3,25310,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25310,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,25310,1,5,0)
 ;;=5^HX OF COLONIC MALIGNANCY
 ;;^UTILITY(U,$J,358.3,25310,2)
 ;;=^295207
 ;;^UTILITY(U,$J,358.3,25311,0)
 ;;=V10.06^^147^1587^40
 ;;^UTILITY(U,$J,358.3,25311,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25311,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,25311,1,5,0)
 ;;=5^HX-RECTAL ANAL MALIGN
 ;;^UTILITY(U,$J,358.3,25311,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,25312,0)
 ;;=V10.07^^147^1587^13
 ;;^UTILITY(U,$J,358.3,25312,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25312,1,4,0)
 ;;=4^V10.07
 ;;^UTILITY(U,$J,358.3,25312,1,5,0)
 ;;=5^HX OF LIVER MALIGNANCY
 ;;^UTILITY(U,$J,358.3,25312,2)
 ;;=^295209
 ;;^UTILITY(U,$J,358.3,25313,0)
 ;;=V10.09^^147^1587^8
 ;;^UTILITY(U,$J,358.3,25313,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25313,1,4,0)
 ;;=4^V10.09
 ;;^UTILITY(U,$J,358.3,25313,1,5,0)
 ;;=5^HX OF GI MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,25313,2)
 ;;=^295210
 ;;^UTILITY(U,$J,358.3,25314,0)
 ;;=V10.11^^147^1587^22
 ;;
 ;;$END ROU IBDEI1FF
